Genitourinary (GU) Cancers Symposium

Full-length androgen receptor (AR-FL) copy number derived from circulating tumor cells detected using a liquid biopsy.

A phase 3 study presented at the 2017 Genitourinary Cancers Symposium demonstrated the feasibility of conducting adjuvant trials.

Researchers identified nearly 80 significantly mutated genes in prostate cancer, including many novel genes and pathways.

The Decipher genomic classifier obtained from biopsy samples was prognostic for distant metastases and prostate cancer-specific mortality.

Despite early failures, there may be a role for single-agent and combination immunotherapy for patients with prostate cancer.

The risk for developing prostate cancer is more than 5 times higher for men in the top 1% of the genetic risk score group.